Fujisawa-Sehara A, Sogawa K, Yamane M, Fujii-Kuriyama Y
Nucleic Acids Res. 1987 May 26;15(10):4179-91. doi: 10.1093/nar/15.10.4179.
The DNA element governing the inducible expression of drug-metabolizing P-450c gene by xenobiotic treatments was investigated by gene transfer methods. A variety of dissected fragments from -844 to -1140bp region which was essential for the inducibility of P-450c gene were placed on the heterologous SV40 promoter for testing the inducibility. Mapping studies in combination with gel retardation assay defined the presence of the two xenobiotic responsive elements (XRE, XRE1, -1007 - -1021bp; XRE2, -1088 - -1092bp) composed of about 15 nucleotides which expressed the enhancer activity in response to xenobiotic inducers. The two XREs share 10 nucleotides in common out of 15 as expressed in the sequence CG/CTG/CC/TTG/CTCACGCT/AA and are arranged in the inverse orientation. They are different from DREs (drug responsive element) proposed previously (Sogawa, K. et al. Proc. Natl. Acad. Sci. 83, 8044-8048 (1986] and expressed a strong enhancer activity in response to 3-methylcholanthrene. The XRE shows a significant homology with glucocorticoid regulatory elements and apparently needs normal functions of a putative xenobiotic receptor for the inducible enhancer activity.
通过基因转移方法研究了通过异生物质处理控制药物代谢P-450c基因诱导表达的DNA元件。将来自-844至-1140bp区域的各种切割片段(这对P-450c基因的诱导性至关重要)置于异源SV40启动子上以测试诱导性。结合凝胶阻滞分析的定位研究确定了两个异生物质反应元件(XRE,XRE1,-1007至-1021bp;XRE2,-1088至-1092bp)的存在,它们由约15个核苷酸组成,可响应异生物质诱导剂表达增强子活性。这两个XRE在15个核苷酸中有10个共同核苷酸,序列为CG/CTG/CC/TTG/CTCACGCT/AA,并以反向排列。它们不同于先前提出的DREs(药物反应元件)(Sogawa,K.等人,《美国国家科学院院刊》83,8044 - 8048(1986年)),并且对3-甲基胆蒽有强烈的增强子活性。XRE与糖皮质激素调节元件有显著同源性,显然需要假定的异生物质受体的正常功能来实现诱导性增强子活性。